Feb 17, 2014 | Digital Pathology, Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology, Uncategorized
Experts are excited about the swift development of wireless remote monitoring of patients; companies expected to develop sensors that incorporate a wide range of biomarkers
Some experts predict that the era of wireless, remote monitoring of patients is almost upon us. It will require pathologists and medical laboratory professionals to learn a new acronym: MBAN, which stands for medical body area network.
There is keen interest in remote wireless monitoring systems. The concept is to free patients from the hospital bed and allow continuous remote monitoring, regardless of where the patient is located. For this reason, in just a few years and in many local markets, opportunities are likely to be ripe for pathologists and clinical laboratory teams to have a role in managing wireless medical devices that use MBANs. (more…)
Feb 27, 2012 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Pathology
Pathologists take note! In-car health management services are intended to further patient-centered healthcare
If a smartphone can be configured to perform a medical laboratory test, then why can’t some clinical lab tests be performed by an automobile? Believe it or not, several car companies are preparing to introduce these types of features into their automobiles in coming years!
First out of the box with the concept of “lab testing in an automobile” are carmakers Ford Motor Company (NYSE: F) and Toyota Motor Corporation (NSYE: TM). Each company has teamed up with healthcare device companies to develop in-car connectivity solutions. The goal is to provide in-vehicle medical testing capabilities that empower consumers with chronic illnesses or medical disorders to manage their condition while on the road.
(more…)
Apr 15, 2011 | Instruments & Equipment, Laboratory News, Laboratory Pathology
Informed consumers fuel double digit increases in sales of defibrillators specifically manufactured for home use
One of the fastest-growing markets in healthcare is the sale of defibrillators to consumers for home use. In fact, independent market research publisher Kalorama Information expects defibrillators for home use to be the number one growth item in the home care products industry through 2014!
Dark Daily believes the rapid growth in defibrillators for home use is an auspicious sign for the clinical laboratory testing industry. It demonstrates the willingness of consumers to take on the responsibilities for sophisticated medical procedures performed at home. That will include a wide range of medical laboratory tests, designed specifically to be used by consumers in their homes.
(more…)
Apr 4, 2011 | Digital Pathology, Laboratory News, Laboratory Pathology
Experts at National Comprehensive Cancer Network conference voice opinions
It may surprise many pathologists and clinical laboratory managers to learn that a number of prominent healthcare leaders recently voiced significant reservations about the current status of molecular genetics testing. In their view, clinical pathology laboratory testing that incorporates genetic and molecular technologies needs further refinement, improved billing codes, and additional regulation before it can fulfill its potential to be a precise diagnostic tool.
That was the conclusion reached by a panel of distinguished physicians representing healthcare organizations, pharmaceutical giants, insurance companies, and the government at this year’s annual National Comprehensive Cancer Network (NCCN) conference.
(more…)
Mar 16, 2011 | Digital Pathology, Laboratory News, Laboratory Pathology
Image quality of wireless device screens may already be good enough for basic digital pathology use
When the U.S. Food and Drug Administration (FDA) recently cleared—for the first time—a mobile application (app) for Radiology Diagnostics, it set the scene for similar mobile apps to gain FDA clearance for use in evaluating digital pathology images.
Both pathologists and clinical laboratory managers are likely to be intrigued with how swiftly mobile computing technology can adapted for use with healthcare images. Earning the honors as the first mobile app to be cleared by the FDA for use with radiology images is the Mobile MIM software, developed by MIM Software, Inc. of Cleveland, Ohio.
(more…)
